04/17/2026 13:00
Qualcomm Announces Quarterly Cash Dividend

Qualcomm Incorporated (NASDAQ: QCOM) today announced a quarterly cash dividend of $0.92 per common share, payable on June 25, 2026, to stockholders of record at the close of business on June 4, 2026. About Qualcomm Qualcomm relentlessly innovates to deliver intelligent computing everywhere, helping the world tackle some of its most important challenges. Building on our 40 years of technology leadership in creating era-defining breakthroughs, we deliver a broad portfolio of solutions built w...

Indonesia orangutan forest cleared for 'carbon-neutral' packaging firm

Vast tracts of Indonesian rainforest home to endangered orangutans have been cleared for plantations supplying a maker of "carbon-neutral" packaging, an investigation by AFP and The Gecko Project has found.

Vast tracts of Indonesian rainforest home to endangered orangutans have been cleared for plantations supplying a maker of "carbon-neutral" packaging, an investigation by AFP and The Gecko Project has found.
05/27/2026 01:02
ASC26 Student Supercomputer Challenge Concluded

The 2026 ASC Student Supercomputer Challenge (ASC26) Finals recently concluded in Wuxi, China, after five days of exciting, high-intensity competition. Demonstrating exceptional performance, teamwork, and innovation, the teams from Peking University and Tsinghua University stood out among the finalists, proudly earning the championship and runner-up titles, respectively. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526720320/en...

04/28/2026 12:42
Vensica Medical Receives FDA IND Clearance to Initiate Phase 2 Study of ViXe, Its Needle-Free Xeomin® Delivery System for Overactive Bladder

Vensica Medical, a clinical-stage company developing needle-free therapeutic delivery solutions for urologic diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application to initiate a Phase 2 clinical trial of ViXe. The study will evaluate the Vibe® ultrasound-based, needle-free drug delivery system in combination with Xeomin® (incobotulinumtoxinA) for the treatment of overactive bladder (OAB). This press releas...

AFP and Jiji Press Announce Launch of “Fastlook” Japanese News Platform

Agence France-Presse (AFP) and Jiji Press today announced the launch of “Fastlook”, a new platform that will bring AFP’s unparalleled global news coverage to corporate and institutional clients in Japanese. This is the first collaborative service in our more than 75-year history.

Agence France-Presse (AFP) and Jiji Press today announced the launch of “Fastlook”, a new platform that will bring AFP’s unparalleled global news coverage to corporate and institutional clients in Japanese. This is the first collaborative service in our more than 75-year history.
Anglais